VALIANT ORGANICS LIMITED Fair Value
VALIANTORG · Chemicals · Current price ₹287.5
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹161 | 5% ROE fading to 14% over ~10 yrs, on ₹236 book |
| Relative P/E | ₹554 | EPS × 45.2 peer-median P/E |
| Graham floor | ₹255 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is VALIANT ORGANICS LIMITED undervalued?
DocStoX estimates the fair value of VALIANT ORGANICS LIMITED at ₹284 per share, versus the current market price of ₹288. That puts the stock about -1.4% above our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹161), Relative P/E (₹554), Graham floor (₹255). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹161 (bear) to ₹284 (base) to ₹554 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on VALIANT ORGANICS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.